Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants.

Shu-Yein HoMei-Hsia YuanChu-Chieh ChenPo-Hong LiuChia-Yang HsuYi-Hsiang HuangHao-Jan LeiRheun-Chuan LeeTeh-Ia Huo

Published in: Digestive diseases and sciences (2020)

DM is highly prevalent in HCC patients and has a distinct survival impact. DM is an independent survival predictor among patients within the Milan criteria and good performance status. These high-risk patients should be closely monitored, and aggressive anticancer treatment should be considered.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
lymph node
type diabetes
metabolic syndrome
patient reported outcomes
skeletal muscle
weight loss